RHUMBLINE ADVISERS - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 91 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 42.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$556
+79.9%
1,8660.0%0.00%
Q2 2023$309
-99.8%
1,866
-97.0%
0.00%
Q1 2021$162,000
+3.2%
62,904
+0.2%
0.00%
Q4 2020$157,000
+28.7%
62,804
+6.6%
0.00%
Q3 2020$122,000
-41.6%
58,904
-12.7%
0.00%
Q2 2020$209,000
+45.1%
67,499
+6.8%
0.00%
Q1 2020$144,000
-37.1%
63,1890.0%0.00%
Q4 2019$229,000
+7.0%
63,189
+0.5%
0.00%
Q3 2019$214,000
-28.2%
62,886
-0.7%
0.00%
-100.0%
Q2 2019$298,000
+34.8%
63,336
-3.9%
0.00%
Q1 2019$221,000
+24.2%
65,934
-1.3%
0.00%
Q4 2018$178,000
-27.9%
66,836
+51.5%
0.00%
Q3 2018$247,000
+2.5%
44,116
-7.1%
0.00%
Q2 2018$241,000
+6.6%
47,466
+43.5%
0.00%
Q1 2018$226,000
-1.7%
33,074
+8.7%
0.00%
Q4 2017$230,000
+6.5%
30,434
-18.8%
0.00%
Q3 2017$216,000
+17.4%
37,464
+3.2%
0.00%
Q2 2017$184,00036,2850.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,196,527$16,526,0003.00%
BVF INC/IL 5,328,239$27,547,0001.08%
Soleus Capital Management, L.P. 740,000$3,826,0000.60%
Cutter & CO Brokerage, Inc. 326,100$1,686,0000.40%
EAM Investors, LLC 288,459$1,491,0000.25%
PLATINUM INVESTMENT MANAGEMENT LTD 1,028,322$5,316,0000.15%
Rhenman & Partners Asset Management AB 300,000$1,551,0000.11%
Navis Wealth Advisors, LLC 16,000$83,0000.06%
Sigma Planning Corp 364,484$1,884,0000.06%
XTX Topco Ltd 32,650$169,0000.06%
View complete list of PIERIS PHARMACEUTICALS INC shareholders